EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-session radiofrequency ablation for the treatment of benign cystic thyroid nodules: A prospective study

Van Bang Nguyen iD, Trong Binh Le, Chi Le Van

PLOS One · 2026

DOI: 10.1371/journal.pone.0341556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Van Bang Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center of Endocrinology and Diabetes, Family Hospital, Da Nang, Vietnam. Hauptthemen laut MEDLINE: Cysts, Radiofrequency Ablation, Thyroid Nodule. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Benign cystic thyroid nodules are commonly encountered in clinical practice and often require intervention due to compressive symptoms or cosmetic concerns. While ethanol ablation (EA) has been widely used, radiofrequency ablation (RFA) has emerged as a promising alternative, particularly for nodules with a significant solid component. This study aimed to evaluate the short-term efficacy and safety of single-session RFA in treating purely cystic and predominantly cystic thyroid nodules (PCTNs).

Methods

This prospective study included 38 patients with benign cystic thyroid nodules (10 purely cystic and 28 PCTNs) treated with single-session RFA. Pre- and post-treatment evaluations were performed using ultrasound imaging and thyroid function tests at 1, 6, and 12 months. The primary endpoint was volume reduction rate (VRR), and therapeutic success was defined as VRR > 50%. Complications were assessed according to international image-guided tumor ablation criteria. This study was registered at ClinicalTrials.gov (identifier: NCT07115576).

Results

RFA resulted in significant volume reduction, with VRR improving from 65.97 ± 22.19% at 1 month to 83.29 ± 17.33% at 6 months and 82.49 ± 23.18% at 12 months (p = 0.004). Purely cystic nodules demonstrated higher VRR than PCTNs at all follow-up points (p < 0.05). Thyroid function remained stable post-procedure. The therapeutic success rate was 83.3% at 1 month and 86.7% at 12 months, with no major complications reported. Purely cystic nodules showed a consistently higher and more durable response than PCTNs.

Conclusion

Single-session RFA appears to be a safe and effective minimally invasive treatment option for large benign thyroid nodules, although confirmation in comparative studies is needed. The technique is particularly advantageous for purely cystic nodules and offers a minimally invasive alternative to surgery or multiple EA sessions.

Trial registration

ClinicalTrials.gov NCT07115576

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CystsRadiofrequency AblationThyroid NoduleAdultAgedFemaleHumansMaleMiddle AgedCatheter AblationProspective StudiesTreatment OutcomeUltrasonography

Autor:innen und Institutionen

  • Center of Endocrinology and Diabetes, Family Hospital, Da Nang, Vietnam.
  • Department of Internal Medicine, Hue University of Medicine and Pharmacy, Hue University, Hue City, Vietnam.
  • Department of Radiology, Hue University of Medicine and Pharmacy, Hue University, Hue City, Vietnam.

ORCID-Profile: Van Bang Nguyen

Zitieren

APA

Nguyen, V. B., Le, T. B., & Van, C. L. (2026). Single-session radiofrequency ablation for the treatment of benign cystic thyroid nodules: A prospective study. PLOS One. https://doi.org/10.1371/journal.pone.0341556

Vancouver

Nguyen VB, Le TB, Van CL. Single-session radiofrequency ablation for the treatment of benign cystic thyroid nodules: A prospective study. PLOS One. 2026. doi:10.1371/journal.pone.0341556

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Van Bang and Le, Trong Binh and Van, Chi Le},
  title = {Single-session radiofrequency ablation for the treatment of benign cystic thyroid nodules: A prospective study},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0341556}
}
Kostenlos starten →